←All events
Climate · binary

Hantavirus vaccine in 2026?

Vol total$131K
Vol 24h$936
Liquidity$32K
Resolves132d

Place your bet

Prediction

Hantavirus vaccine in 2026?

Your pick: Yes — each share pays $1 if Yes wins.

Bets from $1 · deposits start at $3.

SideYes
Price$0.0550
Shares (est)90.91
Spend$5.00
Capital back$5.00
Profit if Yes wins+$85.91
If Yes wins pays$90.91
Connecting your wallet… (usually under 2s)

You sign every order from your embedded wallet. Vectorial Data never holds your funds.

Price history0.00% · 1W
4%5%6%7%8%Aug 14Aug 16Aug 17Aug 18Aug 20Aug 21

Resolution rules

This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.